Multiple endocrine neoplasia type 1 risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:
:* Positive [[family history]]
:* Positive [[family history]]
:* History of [[Zollinger-Ellison syndrome]]
:* History of [[Zollinger-Ellison syndrome]]
:* [[Pituitary disease|Pituitary dysfunction]]
:* [[Pituitary disease|Pituitary dysfunction]] <ref name="pmid28458907">{{cite journal| author=Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Usui T et al.| title=Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy. | journal=Endocrinol Diabetes Metab Case Rep | year= 2017 | volume= 2017 | issue=  | pages=  | pmid=28458907 | doi=10.1530/EDM-17-0027 | pmc=5404709 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28458907  }} </ref>


==References==
==References==

Revision as of 16:49, 6 October 2017

Multiple endocrine neoplasia type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple endocrine neoplasia type 1 risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 1 risk factors

CDC on Multiple endocrine neoplasia type 1 risk factors

Multiple endocrine neoplasia type 1 risk factors in the news

Blogs on Multiple endocrine neoplasia type 1 risk factors

Directions to Hospitals Treating Multiple endocrine neoplasia type 1

Risk calculators and risk factors for Multiple endocrine neoplasia type 1 risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Common risk factors in the development of multiple endocrine neoplasia type-1 are family history, history of Zollinger-Ellison syndrome and pituitary dysfunction.

Risk Factors

References

  1. de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML; et al. (2012). "Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors". Eur J Endocrinol. 167 (2): 181–7. doi:10.1530/EJE-12-0210. PMID 22581216.
  2. Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Usui T; et al. (2017). "Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy". Endocrinol Diabetes Metab Case Rep. 2017. doi:10.1530/EDM-17-0027. PMC 5404709. PMID 28458907.

Template:WS Template:WH